Offers drug product CDMO services from formulation design and clinical materials through commercial manufacturing and packaging, including complex oral solids, injectables, and ophthalmic products.
Company database
Profiles, sources, and comparisons are open. Choose a field on the left to see its companies.
Search & refine Filters update automatically
Disease tags identify mentions in recorded facts or pipeline text, not approved indications or a complete pipeline. Platform service providers may have no disease-specific tag.
3 matching companiesShowing 1–3 / 3
Offers formulation and process concept design, preformulation, development, and manufacturing, with additional disclosed expertise in semisolid and ophthalmic dosage forms.
The 2025 annual report attributes revenue to eye-drop production/sales, contract manufacturing, and technical services. The website explicitly describes integrated ophthalmic product design, R&D, and CMO/CDMO.
Coverage expands from sourced records; this database does not claim all biopharma companies.